Array CGH as a potential predictor of radiocurability in intermediate risk prostate cancer

Author： Ishkanian Adrian S.   Zafarana Gaetano   Thoms John   Bristow Robert G.  

Publisher： Informa Healthcare

ISSN： 0284-186X

Source： Acta Oncologica, Vol.49, Iss.7, 2010-10, pp. : 888-894

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Profiling Breast Cancer by Array CGH

By Albertson D.G.  

Breast Cancer Research and Treatment, Vol. 78, Iss. 3, 2003-04 ,pp. : 289-298

Springer Publishing Company

Access to resources Recommend Favorite

Treatment for intermediate and high-risk prostate cancer: Controversial issues and the role of hyperthermia

By Maluta Sergio   Dall'oglio Stefano   Nadalini Luisa  

International Journal of Hyperthermia, Vol. 26, Iss. 8, 2010-12 ,pp. : 765-774

Informa Healthcare

Access to resources Recommend Favorite

What defines intermediate-risk prostate cancer? Variability in published prognostic models

By Williams S.G.   Millar J.L.   Dally M.J.   Sia S.   Miles W.   Duchesne G.M.  

International Journal of Radiation Oncology*Biology*Physics, Vol. 58, Iss. 1, 2004-01 ,pp. : 11-18

Elsevier

Access to resources Recommend Favorite

Intermediate filament expression in prostate cancer

By Nagle R.B.  

Cancer and Metastasis Reviews, Vol. 15, Iss. 4, 1996-12 ,pp. : 473-482

Springer Publishing Company

Access to resources Recommend Favorite

Caveolin-1 as a potential high-risk prostate cancer biomarker

By                        

Oncology Reports, Vol. 27, Iss. 3, 2012-01 ,pp. : 831-841

Spandidos Publications

Access to resources Recommend Favorite